PCA
MEDP icon

Pallas Capital Advisors’s Medpace MEDP Stock Holding History

Pallas Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
2,142
-1,148
-35% -$530K 0.03% 324
2026
Q1 		$1.58M Sell
3,290
-2,561
-44% -$1.31M 0.06% 237
2025
Q4 		$3.29M Buy
5,851
+1,278
+28% +$725K 0.11% 148
2025
Q3 		$2.35M Buy
4,573
+2,773
+154% +$1.21M 0.09% 185
2025
Q2 		$565K Sell
1,800
-1,119
-38% -$336K 0.02% 466
2025
Q1 		$889K Sell
2,919
-351
-11% -$118K 0.04% 319
2024
Q4 		$1.09M Buy
3,270
+2,101
+180% +$713K 0.05% 218
2024
Q3 		$384K Sell
1,169
-1
-0.1% -$380 0.02% 410
2024
Q2 		$496K Buy
+1,170
New +$463K 0.02% 308

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pallas Capital Advisors's MEDP Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Medpace (MEDP) stake by 35% in Q2 2026, selling an estimated $530K and leaving 2,142 shares worth $1.13M. The position accounts for 0.03% of the portfolio, ranked #324.

Pallas Capital Advisors first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.29M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pallas Capital Advisors held 2,142 shares of Medpace worth $1.13M as of Q2 2026.
  • Pallas Capital Advisors sold 1,148 Medpace shares in Q2 2026, an estimated $530K.
  • Medpace made up 0.03% of Pallas Capital Advisors's portfolio in Q2 2026, its #324 holding.
  • Pallas Capital Advisors first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Pallas Capital Advisors's Medpace position peaked at $3.29M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.